CLREX
Price
$55.57
Change
+$0.22 (+0.40%)
Updated
Sep 3 closing price
Net Assets
10.08B
RLBCX
Price
$37.30
Change
+$0.11 (+0.30%)
Updated
Sep 3 closing price
Net Assets
256.45B
Interact to see
Advertisement

CLREX vs RLBCX

Header iconCLREX vs RLBCX Comparison
Open Charts CLREX vs RLBCXBanner chart's image
Columbia Balanced Inst2
Price$55.57
Change+$0.22 (+0.40%)
VolumeN/A
Net Assets10.08B
American Funds American Balanced R3
Price$37.30
Change+$0.11 (+0.30%)
VolumeN/A
Net Assets256.45B
CLREX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CLREX vs. RLBCX commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLREX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 256B vs. CLREX (10.1B). CLREX pays higher dividends than RLBCX: CLREX (1.87) vs RLBCX (1.53). CLREX was incepted earlier than RLBCX: CLREX (15 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than CLREX (0.65). CLREX is a more actively managed with annual turnover of: 200.00 vs. RLBCX (44.00). CLREX has a lower initial minimum investment than RLBCX: CLREX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 8.12 vs. CLREX (5.72). RLBCX return over 5 years is better than : 36.33 vs. CLREX (26.95).
CLREXRLBCXCLREX / RLBCX
Total Expense Ratio0.650.8973%
Annual Report Gross Expense Ratio0.650.8973%
Fund Existence15 years23 years-
Gain YTD8.9589.86191%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets10.1B256B4%
Annual Yield % from dividends1.871.53122%
Returns for 1 year5.728.1270%
Returns for 3 years34.5636.2395%
Returns for 5 years26.9536.3374%
Returns for 10 years75.3472.59104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EPS67.090.40
+0.60%
WisdomTree U.S. LargeCap Fund
BMED26.340.05
+0.18%
iShares Health Innovation Active ETF
NCZ13.490.01
+0.07%
Virtus Convertible & Income Fund II
ASEA17.18-0.04
-0.23%
Global X FTSE Southeast Asia ETF
MVLL13.32-1.02
-7.11%
GraniteShares 2x Long MRVL Daily ETF